Anticoagulant therapy for percutaneous coronary intervention

SV Rao, EM Ohman - Circulation: Cardiovascular Interventions, 2010 - Am Heart Assoc
Percutaneous coronary intervention (PCI) is the most commonly performed invasive
therapeutic cardiac procedure and plays an important role in the treatment of ischemic heart …

Periprocedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and …

A Rubboli, M Colletta, J Herzfeld… - Coronary Artery …, 2007 - journals.lww.com
Objectives The optimal antithrombotic treatment for patients on long-term anticoagulation
undergoing invasive coronary procedures is currently undefined. The strategies adopted …

The CIAO (Coronary Interventions Antiplatelet-based Only) Study: a randomized study comparing standard anticoagulation regimen to absence of anticoagulation for …

E Stabile, W Nammas, L Salemme, G Sorropago… - Journal of the American …, 2008 - jacc.org
Objectives: We sought to evaluate, in a double-blind, randomized, prospective study, safety
and efficacy of elective percutaneous coronary intervention (PCI), with pharmacotherapy …

Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey

D Cao, R Chandiramani, M Chiarito… - European Heart …, 2021 - academic.oup.com
Since its introduction in 1977, percutaneous coronary intervention has become one of the
most commonly performed therapeutic procedures worldwide. Such widespread diffusion …

Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation

G Helft, M Gilard, C Le Feuvre, AG Zaman - Nature Clinical Practice …, 2006 - nature.com
Antiplatelet therapy with aspirin and clopidogrel is standard care following revascularization
by percutaneous coronary intervention with stent insertion. This so-called dual therapy is …

[PDF][PDF] Antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary artery stenting: safety and efficacy data from a single …

A Rubboli, M Colletta, P Sangiorgio, G Di Pasquale - Ital Heart J, 2004 - ifcardio.org
Background. Dual antiplatelet therapy is the antithrombotic treatment generally
recommended after percutaneous coronary intervention with stent implantation (PCI-S) …

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome

SV Pham, PCT Pham, PMT Pham… - Drug Design …, 2010 - Taylor & Francis
In patients undergoing percutaneous coronary intervention (PCI) for acute coronary
syndrome (ACS), both periprocedural acute myocardial infarction and bleeding …

Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

JJ Popma, P Berger, EM Ohman, RA Harrington… - Chest, 2004 - Elsevier
This chapter about antithrombotic therapy during percutaneous coronary intervention (PCI)
is part of the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy …

Oral anticoagulant therapy during and after coronary angioplasty: the intensity and duration of anticoagulation are essential to reduce thrombotic complications

JM Berg, BA Hutten, JC Kelder, FWA Verheugt… - Circulation, 2001 - Am Heart Assoc
Background—In the randomized Balloon Angioplasty and Anticoagulation Study (BAAS), the
addition of oral anticoagulants to aspirin significantly reduced early and late events after …

Drug insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options

MT Rothman - Nature Clinical Practice Cardiovascular Medicine, 2005 - nature.com
In Europe, the use of interventional cardiology, including percutaneous coronary
intervention (PCI), is increasing rapidly. The use of anticoagulation agents in PCI …